HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Guillaume Direz Selected Research
Guillaume Direz Research Topics
Disease
2
Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
03/2024 - 01/2022
1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2023
1
Infections
01/2022
1
Vasculitis (Vasculitides)
12/2018
1
Arthritis (Polyarthritis)
12/2018
1
Demyelinating Diseases (Demyelinating Disease)
05/2013
1
Gout
12/2012
1
Chronic Kidney Failure (Chronic Renal Failure)
12/2012
1
Rheumatic Diseases (Rheumatism)
12/2011
1
Uveitis
12/2011
1
Rheumatoid Arthritis
12/2011
1
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2011
1
Spondylarthropathies
12/2011
1
Inflammation (Inflammations)
12/2011
Drug/Important Bio-Agent (IBA)
2
Glucocorticoids
IBA
03/2024 - 01/2022
2
C-Reactive Protein
IBA
03/2024 - 01/2022
2
tocilizumab (atlizumab)
FDA Link
03/2024 - 01/2022
2
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
11/2023 - 12/2018
1
Rituximab (Mabthera)
FDA Link
11/2023
1
Azathioprine (Imuran)
FDA Link
Generic
11/2023
1
dimemorfan (AT 17)
IBA
01/2022
1
Prednisone (Sone)
FDA Link
Generic
01/2022
1
Interleukin-6 (Interleukin 6)
IBA
01/2022
1
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
12/2012
1
Infliximab (Remicade)
FDA Link
12/2011
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2011
1
Etanercept (Enbrel)
FDA Link
12/2011
1
Adalimumab (Humira)
FDA Link
12/2011
1
Monoclonal Antibodies
IBA
12/2011
1
Tumor Necrosis Factor Inhibitors
IBA
12/2011
Therapy/Procedure
5
Therapeutics
11/2023 - 12/2011